Penumbra Ownership | Who Owns Penumbra?
Penumbra Ownership Summary
Penumbra is owned by 91.31% institutional investors, 3.60% insiders, and 5.09% retail investors. Fmr is the largest institutional shareholder, holding 15.07% of PEN shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.24% of its assets in Penumbra shares.
PEN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Penumbra | 91.31% | 3.60% | 5.09% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Medical Device Stocks | 52.08% | 10.61% | 37.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 5.82M | 15.07% | $1.38B |
Blackrock | 4.26M | 10.99% | $765.80M |
Blackrock funding, inc. /de | 4.21M | 10.85% | $1.08B |
Vanguard group | 3.65M | 9.45% | $866.95M |
Champlain investment partners | 1.50M | 3.87% | $355.26M |
Price t rowe associates inc /md/ | 1.27M | 3.28% | $300.58M |
State street | 1.23M | 3.18% | $221.87M |
Rtw investments, lp | 863.55K | 2.22% | $221.61M |
Baillie gifford | 730.23K | 1.89% | $173.42M |
Clearbridge investments | 663.95K | 1.72% | $157.67M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Pfm health sciences, lp | 166.26K | 3.67% | $42.67M |
Rtw investments, lp | 863.55K | 3.16% | $221.61M |
Oak harbor wealth partners | 33.61K | 2.32% | $7.98M |
Champlain investment partners | 1.50M | 2.25% | $355.26M |
Carret asset management | 77.00K | 2.11% | $19.76M |
Rock springs capital management lp | 128.50K | 2.05% | $32.98M |
Exome asset management | 9.00K | 1.46% | $2.31M |
Braidwell lp | 129.63K | 1.14% | $33.27M |
Next century growth investors | 49.74K | 0.99% | $12.77M |
Bellevue group | 174.05K | 0.98% | $44.67M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Norges bank | 229.05K | 0.01% | 229.05K |
Qube research | 209.71K | 0.05% | 209.71K |
Blackrock | 4.26M | 0.02% | 193.91K |
Baillie gifford | 730.23K | 0.13% | 138.39K |
Steadfast capital management lp | 95.00K | 0.44% | 95.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital research global investors | - | - | -1.13M |
William blair investment management | - | - | -883.10K |
Price t rowe associates inc /md/ | 1.27M | 0.03% | -719.57K |
T. rowe price investment management | 7.95K | 0.00% | -625.66K |
Holocene advisors, lp | - | - | -402.34K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 229.05K | 0.01% | 229.05K | $54.40M |
Qube research | 209.71K | 0.05% | 209.71K | $53.82M |
Steadfast capital management lp | 95.00K | 0.44% | 95.00K | $24.38M |
Acadian asset management | 64.59K | 0.03% | 64.59K | $16.57M |
Tudor investment corp et al | 58.19K | 0.03% | 58.19K | $14.93M |
Sold Out
Holder | Change |
---|---|
Newsquare capital | -1.00 |
Sjs investment consulting | -1.00 |
Innealta capital | -1.00 |
Dinuzzo private wealth | -1.00 |
Harbor investment advisory | -1.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 466 | 5.67% | 35,458,549 | 3.11% | 91 | 1.15% | 251 | 5.02% | 143 | 10.85% |
Mar 31, 2025 | 440 | 15.49% | 34,552,725 | -1.08% | 89 | 1.09% | 237 | 24.74% | 130 | -2.99% |
Dec 31, 2024 | 188 | -46.29% | 15,184,979 | -56.57% | 39 | 0.48% | 87 | -42.00% | 67 | -53.15% |
Sep 30, 2024 | 346 | -3.89% | 34,876,344 | -1.99% | 90 | 1.07% | 147 | -25.76% | 142 | 33.96% |
Jun 30, 2024 | 357 | -2.99% | 35,576,747 | 6.43% | 91 | 1.21% | 196 | 7.10% | 105 | -1.87% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Mid-Cap ETF | 1.26M | 3.24% | -2.25K |
Vanguard US Total Market Shares ETF | 1.16M | 3.02% | 924.00 |
Vanguard Total Stock Mkt Idx Inv | 1.16M | 2.96% | -24.39K |
Fidelity Select Health Care | 1.08M | 2.77% | - |
Vanguard Small Cap Index | 893.06K | 2.29% | -5.87K |
Fidelity Select Medical Tech and Devcs | 847.00K | 2.17% | 27.24K |
US Small-Cap Growth II Equity Comp | 807.21K | 2.08% | -1.98K |
T. Rowe Price Health Sciences | 639.14K | 1.65% | 78.70K |
Fidelity Advisor Health Care I | 608.00K | 1.56% | -10.00K |
Strategic Advisers Fidelity US TtlStk | 604.50K | 1.55% | -5.40K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 02, 2025 | Grewal Harpreet | - | Sell | $50.63K |
Sep 03, 2025 | Elsesser Adam | CEO | Sell | $2.05M |
Sep 03, 2025 | Elsesser Adam | CEO | Sell | $1.26M |
Sep 03, 2025 | Elsesser Adam | CEO | Sell | $631.03K |
Sep 03, 2025 | Elsesser Adam | CEO | Sell | $324.97K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 48 |
2025 Q2 | - | 104 |
2025 Q1 | - | 59 |
2024 Q4 | - | 36 |
2024 Q3 | - | 32 |
PEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools